Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Doni Bloomfield"'
Publikováno v:
Nature Biotechnology. 40:1319-1325
Publikováno v:
Health Affairs. 41:787-796
Publikováno v:
JAMA oncology. 8(4)
Biologics account for almost half of US drug spending but may be subject to competitive pricing pressures by US Food and Drug Administration-approved biosimilars. The extent of the preapproval clinical testing that is needed and how these biosimilars
Publikováno v:
JAMA. 326(14)
Publikováno v:
BMJ. :e068172
Autor:
Doni Bloomfield
Publikováno v:
SSRN Electronic Journal.
The modern law of induced patent infringement contradicts the Patent Act and violates the First Amendment. As currently applied, the law unconstitutionally restricts speech, discourages the entry of generic drugs, and helps keep medicine prices high.
Autor:
Doni Bloomfield
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
JAMA Internal Medicine. 182:245
Autor:
Doni Bloomfield
Publikováno v:
San Francisco Chronicle (10/1/2007 to present); 11/18/2015, pC2, 0p
Autor:
Feldman WB; William B. Feldman (wbfeldman@bwh.harvard.edu), Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Bloomfield D; Doni Bloomfield, United States Court of Appeals for the D.C. Circuit, Washington, D.C., Beall RF; Reed F. Beall, University of Calgary, Calgary, Alberta, Canada., Kesselheim AS; Aaron S. Kesselheim, Brigham and Women's Hospital and Harvard Medical School.
Publikováno v:
Health affairs (Project Hope) [Health Aff (Millwood)] 2022 Jun; Vol. 41 (6), pp. 787-796. Date of Electronic Publication: 2022 May 17.